Polyclonal Rabbit anti‑Human FSP27 / CIDEC Antibody (Preservative Free, IF, WB) LS‑C814775
Polyclonal Rabbit anti‑Human FSP27 / CIDEC Antibody (Preservative Free, IF, WB) LS‑C814775
Antibody:
FSP27 / CIDEC Rabbit anti-Human Polyclonal (Preservative Free) Antibody
Format:
Unconjugated, Preservative Free
Overview
Antibody:
FSP27 / CIDEC Rabbit anti-Human Polyclonal (Preservative Free) Antibody
Format:
Unconjugated, Preservative Free
Specifications
Description
CIDEC antibody LS-C814775 is an unconjugated rabbit polyclonal antibody to human CIDEC (FSP27). Validated for ICC, IF and WB.
Target
Human FSP27 / CIDEC
Synonyms
CIDEC | CIDE3 | CIDE-3 | FSP27 | Cell death activator CIDE-3 | CIDEX | Fat specific protein 27
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Protein A affinity chromatography
Modifications
Preservative Free
Immunogen
A synthetic peptide corresponding to the center region of the Human CIDEC
Applications
- ICC (1:300 - 1:10000)
- Immunofluorescence (1:300 - 1:10000)
- Western blot (1:500 - 1:2000)
Usage
Applications should be user optimized.
Presentation
0.2 µm filtered solution in PBS
Storage
Store at 2°C to 8°C for up to 1 month. Aliquot and store at -20°C to -80°C for up to 1 year. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat
Applications:
IHC, Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, ICC, Immunofluorescence, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Peptide Enzyme-Linked Immunosorbent Assay
Reactivity:
Human
Range:
0.156-10 ng/ml
Reactivity:
Rat
Range:
24-15000 pg/ml
Reactivity:
Monkey
Range:
0.313-20 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 8/31/2024